Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-011147
Filing Date
2025-08-12
Accepted
2025-08-12 07:23:55
Documents
75
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q zbio-20250630x10q.htm   iXBRL 10-Q 2726368
2 EX-10.1 zbio-20250630xex10d1.htm EX-10.1 19021
3 EX-10.2 zbio-20250630xex10d2.htm EX-10.2 32777
4 EX-31.1 zbio-20250630xex31d1.htm EX-31.1 15575
5 EX-31.2 zbio-20250630xex31d2.htm EX-31.2 15179
6 EX-32.1 zbio-20250630xex32d1.htm EX-32.1 8168
7 EX-32.2 zbio-20250630xex32d2.htm EX-32.2 8000
8 GRAPHIC zbio-20250630x10q004.jpg GRAPHIC 6769
9 GRAPHIC zbio-20250630xex10d1001.jpg GRAPHIC 5551
10 GRAPHIC zbio-20250630xex10d2001.jpg GRAPHIC 5354
  Complete submission text file 0001558370-25-011147.txt   7963455

Data Files

Seq Description Document Type Size
11 EX-101.SCH zbio-20250630.xsd EX-101.SCH 43423
12 EX-101.CAL zbio-20250630_cal.xml EX-101.CAL 49751
13 EX-101.DEF zbio-20250630_def.xml EX-101.DEF 154875
14 EX-101.LAB zbio-20250630_lab.xml EX-101.LAB 410655
15 EX-101.PRE zbio-20250630_pre.xml EX-101.PRE 300594
78 EXTRACTED XBRL INSTANCE DOCUMENT zbio-20250630x10q_htm.xml XML 1058344
Mailing Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451
Business Address 852 WINTER STREET, SUITE 250 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Filer) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)